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O R I G I N A L  R E S E A R C H
Abstract: Older adults with cardiovascular disease (CVD) often report experiencing significant
cognitive dysfunction in everyday life and exhibit deficits on neuropsychological testing.
However, the relationship between subjective and objective cognitive dysfunction is inconsistent
across studies and requires closer examination. Participants included 84 older adults with
documented CVD and no history of neurological or severe psychiatric disorder. All participants
underwent echocardiogram and neuropsychological assessment and completed self-report
measures of perceived cognitive dysfunction, depression, and health-related quality of life.
Results showed that concerns regarding distractibility and sustained attention were most
common. Level of reported cognitive dysfunction was significantly related to depressive
symptoms, quality of life, and performance on multiple cognitive tests. Exploratory regression
analyses showed that depressive symptoms, physical health-related quality of life, and speeded
sustained attention predicted reports of cognitive dysfunction, whereas demographic variables,
cardiac output, and other cognitive tests did not. Should they be replicated, these findings
suggest that reports of cognitive dysfunction in older adults with CVD largely reflect depressive
symptoms and reduced quality of life.
Keywords: cardiovascular disease, cognition, quality of life, depression
Introduction
There is growing evidence that cardiovascular disease (CVD) is a risk factor for
cognitive dysfunction long prior to onset of stroke or dementia (Mazzucchi et al 1986;
Kalra et al 1993; Grubb et al 1996; Elwood et al 2002; O’Reilly et al 2003; Trojano et
al 2003). These findings are consistent with the notion of vascular cognitive impairment
(VCI), a proposed continuum of cognitive deficits that ranges from “brain at risk” to
vascular dementia (Hachinski and Bowler 1993; Bowler et al 1999). Older adults
with CVD are believed to fall in the middle of this continuum, exhibiting cognitive
deficits and cerebrovascular disease without the functional impairment found in
dementia (Mazzucchi et al 1986; Kalra et al 1993; Grubb et al 1996; Elwood et al
2002; O’Reilly et al 2003; Trojano et al 2003; Cook et al 2004; Kuo and Lipsitz 2004).
Given these findings, it is not surprising that older adults with CVD often report
experiencing significant cognitive dysfunction in everyday life (Khatri et al 1999).
However, less straightforward is the fact that these reports are more closely related
to depressive symptoms than objective test performance (Newman et al 1989; Khatri
et al 1999; Bergh et al 2002). Such findings suggest that older CVD patients lack
insight into their level of cognitive function. Reduced awareness of cognitive function
is not unique to CVD patients and is found in persons with a variety of psychiatric
and neurological conditions. For example, persons with bipolar disorder and patients
in the early stages of dementia also exhibit little awareness of their impairments
(Burdick et al 20005; Spitznagel and Tremont 2005).
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However, methodological concerns of past studies
encourage a re-examination of the relationship between
subjective and objective cognitive impairment in CVD
patients. Careful review shows that previous work often
examined only cardiothoracic surgery patients, selected
predictors from limited domains (ie, only cognitive and
affective), and employed tests that tap cognitive abilities
other than those patients report as being impaired (Newman
et al 1989; Khatri et al 1999; Raja et al 2004). Each of these
methodological choices may distort the observed relation-
ship between reported cognitive dysfunction and test
performance, raising the possibility that reports of cognitive
dysfunction in CVD patients may not be as inaccurate as
originally believed.
To clarify this possibility, the present study examined
self-reported cognitive dysfunction in older adults with
heterogeneous history of CVD. Variables were chosen to
closely match those used in past studies and to extend the
assessment of cognitive abilities that patients reported as
being impaired. Using this method, we hypothesized that
multiple factors, including cognitive performance, would
be related to self-reported cognitive dysfunction of older
adults with CVD.
Methods
The following methods were approved by the local
Institutional Review Board prior to study onset.
Participants
Participants included 84 older adults enrolled in a
prospective study of the neurocognitive consequences of
CVD. They were required to have a documented history of
CVD, a total score on the Mini Mental Status Examination
(MMSE) above cutoff for dementia (Folstein et al 1975),
and no history of neurological or severe psychiatric disorder.
Participants were recruited from cardiology clinic patients
and not selected based on concerns regarding possible
cognitive dysfunction. Participants averaged 69.79 ± 7.87
years of age and 14.41 ± 2.72 years of education. Average
MMSE score (28.52 ± 1.67) and cardiac ejection fraction
(58.87 ± 11.65) were within normal ranges.
In terms of medical history, 46% of participants had a
history of myocardial infarction, 37% coronary artery bypass,
11% valve repair or replacement, 13% heart failure, 74%
hypertension, and 23% type 2 diabetes. Approximately
10% of participants had prior history of mild head injury, 9%
transient ischemic attack, and 13% had history of depression.
Instrumentation
Subjective cognitive complaints
The Cognitive Difficulties Scale (CDS) is a pen-and-paper
measure of subjective difficulties in attention, memory,
perception, and psychomotor abilities (McNair and Kahn
1983). It has been used in both healthy and patient samples,
including persons with CVD (McNair and Kahn 1983;
Derouesne et al 1993; Derouesne et al 1999; Khatri et al
1999). The relationship among the CDS, depression, and
cognitive function varies across studies. Although some
studies show a strong relationship between the CDS and
performance on neuropsychological tests, others find the
CDS is more closely related to affective symptoms than
cognitive dysfunction (Gass and Apple 1997; Derouesne et
al 1999; Khatri et al 1999; Burdick et al 2005; Spitznagel
and Tremont 2005).
Neuropsychological tests
All participants completed a neuropsychological test battery
comprising tasks commonly used during clinical neuro-
psychological evaluation (Table 1). Domains included:
1) Attention (Trailmaking Test Part A [Reitan 1958], Digit
Symbol-Coding [Wechsler 1997], Digit Span [Wechsler
1997], Stroop Color Word Test composite score for Word
and Color trials [Golden 1978]);
2) Executive function (Trail Making Test B [Reitan 1958],
Lexical Fluency [FAS; Eslinger et al 1984], Similarities
[Wechsler 1997], Stroop Color Word Test Interference
[Golden 1978]);
3) Memory (California Verbal Learning Test [Delis et al
1987], Brief Visuospatial Memory Test-Revised
[Benedict 1997]);
4) Language (Boston Naming Test (Kaplan et al 1983],
Category Fluency [Morris et al 1989]);
5) Visuopatial skills (Hooper Visual Organization Test
[Hooper 1983], Block Design [Wechsler 1997]);
6) Motor function (Grooved Pegboard Test for dominant
and nondominant hand [Klove 1963]).
Depression
The Beck Depression Inventory (BDI) assesses vegetative,
affective, and cognitive symptoms of depression and has
been used extensively in patient populations (Beck and Steer
1993; Richter et al 1998).
Quality of life
The Medical Outcomes Study SF-36 (Ware et al 1994) is
a measure of subjective health used extensively in healthy
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and medical populations, including persons with CVD
(Rumsfeld et al 1999, 2001). Its eight domains were
summarized into a Physical Composite Summary (PCS)
and Mental Composite Summary scores (MCS),
representing physical and mental quality of life,
respectively.
Procedure After participants completed a written informed
consent process, all instruments were administered in a one-
to-one format by trained research team members.
Participants completed self-report instruments after
neuropsychological testing.
Data analysis Three sets of analyses were conducted to
better understand the self reported cognitive dysfunction of
older adults with CVD. First, bivariate Pearson correlation
was used to determine the relationship between reported
difficulties on the CDS and objective test performance. An
item analysis was then conducted to identify the cognitive
abilities of greatest concern in our sample. Finally,
exploratory regression analyses were conducted to
determine the relative contribution of various factors to CDS
total score. More specifically, we conducted multiple
regression with backward elimination using CDS total score
as the dependent variable. Predictors included demographic
characteristics, measures of cardiovascular disease,
depressive symptoms, quality of life, and performance on
tests that tap the most commonly reported areas of
dysfunction.
Results
Test performance and reported
cognitive dysfunction
Participants typically performed well  on
neuropsychological testing, with their combined
performance falling within 1.5 standard deviations of the
normative mean on all tests (Table 1). Bivariate
correlation showed that CDS total score was significantly
related to depressive symptoms on the BDI, quality of
life indices from the SF-36, and performance on multiple
neuropsychological tests (Table 1).
Item analysis
An item analysis was then conducted on the CDS. Corrected
item-total correlations were used to identify the cognitive
tasks of greatest concern to our sample of older adults with
CVD. Results showed that difficulties with distractibility
and sustained attention were most common, followed by
language difficulties (Table 2).
Predicting reported cognitive
dysfunction
Finally, exploratory regression analyses were conducted to
examine the relative contribution of various factors to the
subjective cognitive difficulties of older adults with CVD.
Stepwise regression with backward elimination showed
significant prediction of CDS total score (F[3, 56] = 13.31,
Table 1 Neuropsychological test performance, impairment
and correlation to reported cognitive dysfunction
> 1.5
 SD
from Correlation
Test Mean (SD)  mean to CDS
Reported cognitive difficulties
CDS total score 37.32 (21.56) No –
Attention
Trials A 37.76 (12.44) No 0.251
Stroop Word and Color 43.52 (5.83) No –0.362
WAIS-III Digit Span 17.51 (3.95) No –0.14
WAIS-III Symbol Coding 55.40 (13.89) No –0.191
Executive function
Stroop Interference –13.65 (6.87) No 0.15
Trials B 99.57 (51.47) No 0.17
Lexical Fluency (FAS) 36.33 (11.84) No –0.17
WAIS-III Similarities 20.96 (5.24) No –0.14
Memory
CVLT Trials 1–5 Total 46.58 (11.90) No –0.211
CVLT Short Free Recall 9.23 (3.29) No –0.10
CVLT Long Free Recall 9.30 (3.52) No –0.14
CVLT Discrimination 91.33 (7.59) No –0.15
BVMT Trials 1–3 Total 16.83 (6.98) No –0.231
BVMT Delayed Recall 6.94 (3.18) No –0.221
BVMT Discrimination 5.05 (1.15) No –0.241
Language
Boston Naming Test 54.52 (5.65) No –0.191
Category Fluency (Animals) 19.90 (5.53) No –0.05
Visuospatial
HVOT 23.44 (3.74) No 0.03
WAIS-III Block Design 31.85 (11.18) No –0.10
Motor
Grooved Pegboard (D) 95.91 (26.37) No 0.10
Grooved Pegboard (ND) 106.61 (33.41) No 0.10
Mood
Beck Depression Inventory 5.93 (4.49) No 0.552
Quality of life
Physical Component Scale 42.73 (9.50) No –0.281
Mental Component Scale 55.01 (7.73) No –0.452
NOTE: All test scores are raw scores.
1 two-tailed p < 0.05.
2 two-tailed p < 0.01.
Abbreviations: BVMT, Brief Visuospatial Memory Test-Revised; CVLT, California
Verbal Learning Test; CDS, Cognitive Difficulties Scale; D, dominant hand; ND,
nondominant hand; HVOT, Hooper Visual Organization Test; WAIS, Wechsler
Adult Intelligence Scale.
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p < 0.001), with the final model accounting for 41.6% of
the variance (Table 3). Three predictors remained significant,
namely: BDI total score, PCS from the SF-36, and speeded
sustained attention from the Stroop Color Word Test.
Demographic variables, cardiac output, and other cognitive
tests were not retained in the final model.
Discussion
The present study is the first to demonstrate that attention
and language abilities are the most common cognitive
concerns of older CVD patients. Reduced attentional
abilities may be expected in persons with CVD, as they often
show reduced performances on neuropsychological tasks
tapping attention, psychomotor speed, and executive
function (Mazzucchi et al 1986; Kalra et al 1993; Grubb et
al 1996; Elwood et al 2002; O’Reilly et al 2003; Trojano et
al 2003). Language impairment is not traditionally
associated with CVD in the absence of stroke, though word-
finding difficulties are part of both the normal aging process
and a symptom of Alzheimer’s disease (Mackay et al 2002;
Testa et al 2004). Finding that language performance was
within expected ranges implicates normal aging as a likely
cause, but the very early effects of a neurodegenerative
process cannot be fully ruled out. Prospective examination
of our and other samples of CVD patients will help clarify
whether reported word-finding difficulties predict later
conversion to Alzheimer’s disease.
In the present study, reports of cognitive dysfunction
were associated with reduced performance on multiple
cognitive tests. However, the observed relationships were
modest in size (range from –0.19 to –0.36) and explained
little of the total variance. In contrast, depressive symptoms
were closely related to reports of cognitive dysfunction
(r = 0.55). Finding reported cognitive problems are more
closely related to depressive symptoms than actual test
performance is consistent with many past studies (Newman
et al 1989; Khatri et al 1999; Raja et al 2004), though the
exact reason for this relationship remains unclear. Several
possible explanations for this finding exist, including shared
method variance, the known effects of subclinical depression
on cognitive performance, or an as yet unidentified factor
(Wollert and Buchwald 1979).
Analyses also showed that quality of life contributes to
the report of cognitive dysfunction in older adults with CVD.
A relationship between quality of life and reported cognitive
dysfunction has previously been found in healthy and other
patient populations (Collins and Abeles 1996; Dijkstra et al
1998; Levy-Cushman and Abeles 1998). Physical illness is
known to limit cognitive performance in several ways,
including greater distraction, hypervigilance, and pre-
occupation during tasks (Luoto et al 1999; Gasquione 2000).
These changes would adversely impact the same attentional
abilities reported by our sample as being impaired. However,
once again, the effects of shared method variance on this
relationship cannot be fully excluded and replication in other
samples is needed.
The present findings highlight the complicated
relationship among reported cognitive dysfunction,
Table 2 Most common subjective cognitive problems in older
adults with cardiovascular disease
Corrected
item-total
Rank Item
correlation
1 I cannot keep my mind on one thing. 0.76
2 I miss the point of what others are saying. 0.75
3 I have trouble getting out information that is at the
tip of my tongue. 0.71
4 I find it hard to keep my mind on a task or job. 0.70
5 I find it hard to understand what I read. 0.68
6 I forget right away what people say to me. 0.68
7 I need to have instructions repeated several times. 0.68
8 I have trouble describing a program that I just watched
on television. 0.66
9 When interrupted during reading, I have trouble finding
my place again. 0.66
10 I have to do things very slowly to make sure I’m doing
them right. 0.65
Table 3 Predicting cardiovascular disease (CVD) total score in
older adults with CVD
Included variables B b p
Beck Depression Inventory 2.18 0.45 < 0.01
Physical Quality of Life –0.48 –0.21 0.05
Stroop Sustained Attention –1.10 –0.30 < 0.01
Intercept 92.80
R2 = 0.42
Adjusted R2 = 0.39
R = 0.66
Partial
Excluded variables B p correlation
Age 0.03 0.78 0.04
Education –0.12 0.26 –0.15
Cardiac Output 0.12 0.27 0.15
Mental Quality of Life –0.19 0.16 –0.19
Digit Symbol-Coding –0.04 0.77 –0.04
CVLT Trial 1 –0.05 0.63 –0.07
FAS 0.04 0.73 0.05
Boston Naming Test –0.13 0.22 –0.17
Abbreviations: CVLT, California Verbal Learning Test.
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depression, and actual test performance. Like many others,
we found a weak relationship between reported cognitive
dysfunction and actual test performance. This pattern
emerged in our sample with intact test performance.
Interestingly, reported cognitive dysfunction is also
unrelated to actual test performance in Alzheimer’s patients
and psychiatric samples with significant cognitive
impairment (Burdick et al 2005; Spitznagel and Tremont
2005). This pattern suggests two likely explanations. One
possibility is that people generally have little insight into
their level of cognitive function. This inability may well
result from the difficulty in accurately evaluating cognitive
function in everyday life or the effects of limited executive
functioning (which has been associated with reduced
awareness in patient populations (Michon et al 1994; Singh-
Manoux et al 2003; Kuo et al 2004). A second possible
explanation involves the use of cross sectional methodology.
It is possible that between-subject differences (eg, level of
depressive symptoms) obscure more subtle within-subject
changes (eg, reporting a slight change from previous levels).
Prospective examination of reported cognitive dysfunction
and actual test performance are much needed, particularly
studies that collect detailed information regarding subjective
change in cognitive function.
The present study has important implications for
clinicians working with older adults with CVD. Based on
the present findings, CVD patients reporting cognitive
dysfunction are most appropriately referred for neuro-
psychological evaluation to determine the relative
contribution of depressive symptoms, reduced quality of life,
and actual cognitive impairment to these complaints.
Clinicians may also want to consider additional referral to
exercise or rehabilitation program, as they are associated
with improved mood, quality of life, and cognitive
performance in both healthy and patient populations (Barnes
et al 2003; Stewart et al 2003; Gunstad et al 2005).
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